<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6677893</article-id><article-id pub-id-type="pmid">31375711</article-id><article-id pub-id-type="publisher-id">47650</article-id><article-id pub-id-type="doi">10.1038/s41598-019-47650-2</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A portable epigenetic switch for bistable gene expression in bacteria</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Olivenza</surname><given-names>David R.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Nicoloff</surname><given-names>Herv&#x000e9;</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>S&#x000e1;nchez-Romero</surname><given-names>Mar&#x000ed;a Antonia</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Cota</surname><given-names>Ignacio</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6640-2174</contrib-id><name><surname>Andersson</surname><given-names>Dan I.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2308-293X</contrib-id><name><surname>Casades&#x000fa;s</surname><given-names>Josep</given-names></name><address><email>casadesus@us.es</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2168 1229</institution-id><institution-id institution-id-type="GRID">grid.9224.d</institution-id><institution>Departamento de Gen&#x000e9;tica, Facultad de Biolog&#x000ed;a, </institution><institution>Universidad de Sevilla, </institution></institution-wrap>Apartado 1095, 41080 Sevilla, Spain </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 9457</institution-id><institution-id institution-id-type="GRID">grid.8993.b</institution-id><institution>Department of Medical Biochemistry and Microbiology, </institution><institution>Uppsala University, </institution></institution-wrap>751 23 Uppsala, Sweden </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.7080.f</institution-id><institution>Present Address: Centre for Research in Agricultural Genomics, CSIC-IRTA-UAB-UB, Campus UAB, Bellaterra, </institution></institution-wrap>08193 Barcelona, Spain </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>8</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>2</day><month>8</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>9</volume><elocation-id>11261</elocation-id><history><date date-type="received"><day>15</day><month>5</month><year>2019</year></date><date date-type="accepted"><day>22</day><month>7</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">We describe a portable epigenetic switch based on <italic>opvAB</italic>, a <italic>Salmonella enterica</italic> operon that undergoes bistable expression under DNA methylation control. A DNA fragment containing the <italic>opvAB</italic> promoter and the <italic>opvAB</italic> upstream regulatory region confers bistability to heterologous genes, yielding OFF and ON subpopulations. Bistable expression under <italic>opvAB</italic> control is reproducible in <italic>Escherichia coli</italic>, showing that the <italic>opvAB</italic> switch can be functional in a heterologous host. Subpopulations of different sizes can be produced at will using engineered o<italic>pvAB</italic> variants. Controlled formation of antibiotic-resistant and antibiotic-susceptible subpopulations may allow use of the <italic>opvAB</italic> switch in the study of bacterial heteroresistance to antibiotics.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Bacterial synthetic biology</kwd><kwd>DNA methylation</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100003329</institution-id><institution>Ministerio de Econom&#x00026;amp;#x00ED;a y Competitividad (Ministry of Economy and Competitiveness)</institution></institution-wrap></funding-source><award-id>BIO2016-75235-P</award-id><award-id>BIO2016-75235-P</award-id><principal-award-recipient><name><surname>Olivenza</surname><given-names>David R.</given-names></name><name><surname>Cota</surname><given-names>Ignacio</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100004359</institution-id><institution>Vetenskapsr&#x00026;amp;#x00E5;det (Swedish Research Council)</institution></institution-wrap></funding-source><award-id>2017-01527</award-id><award-id>2017-1527</award-id><principal-award-recipient><name><surname>Nicoloff</surname><given-names>Herv&#x000e9;</given-names></name><name><surname>Andersson</surname><given-names>Dan I.</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Biosensors able to detect environmental signals are made of a sensor that detects a given input and a reader that responds to the input generating a detectable signal in a quantitative or semi-quantitative fashion<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Classical sensors employ enzymes or whole cells. Enzyme-based biosensors present the advantage of high selectivity but the need for purification can be a drawback due to technical difficulties and high cost. In contrast, whole-cell sensors are often easy to use and inexpensive, especially if microbial strains are used<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. A common type of microbial biosensor is an engineered strain that responds to physical or chemical inputs generating electrochemical or optical signals. Sensors of this type often employ a promoter sensitive to a specific input and a reporter gene that produces a detectable signal<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR3">3</xref></sup>. The literature contains multiple examples of sensors that detect electrochemical and optical signals, and use of fluorescent proteins has become widespread in the last decade<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>.</p><p id="Par3">An alternative to genetic circuits able to process information in living cells is the design of epigenetic switches. This approach has received special attention to develop diagnostic tests for human diseases<sup><xref ref-type="bibr" rid="CR5">5</xref>&#x02013;<xref ref-type="bibr" rid="CR7">7</xref></sup>, while synthetic biology based on bacterial epigenetics remains largely unexplored. A relevant exception is the recent development of biosensors based on DNA adenine methylation using <italic>Escherichia coli</italic> as host<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>.</p><p id="Par4">In this study, we describe the construction and application of an epigenetic switch that drives gene expression in a bistable fashion. Bistability generates bacterial subpopulations that differ in a specific phenotypic trait (e. g., antibiotic resistance) and have defined sizes. The switch is based on <italic>opvAB</italic>, a bacterial operon subjected to epigenetic control by DNA adenine methylation<sup><xref ref-type="bibr" rid="CR9">9</xref>&#x02013;<xref ref-type="bibr" rid="CR11">11</xref></sup>. Transcription of <italic>opvAB</italic> is bistable, with concomitant formation of OpvAB<sup>OFF</sup> and OpvAB<sup>ON</sup> cells<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. Bistability is controlled by binding of the OxyR transcription factor to a regulatory region upstream of the <italic>opvAB</italic> promoter (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1A</xref>)<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. This region contains four sites for OxyR binding and four GATC motifs. OpvAB<sup>OFF</sup> and OpvAB<sup>ON</sup> cell lineages display alternative patterns of OxyR binding, which in turn cause alternative patterns of GATC methylation: in the OFF state, GATC<sub>2</sub> and GATC<sub>4</sub> are methylated; in the ON state, GATC<sub>1</sub> and GACT<sub>3</sub> are methylated<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. Here, we show that a cassette of 689 nucleotides containing the <italic>opvAB</italic> promoter and the upstream regulatory region confers bistability to heterologous genes, and describe examples of <italic>opvAB</italic>-based constructs that produce bacterial subpopulations with distinct phenotypes. One of the examples involves formation of an antibiotic-resistant subpopulation upon cloning of an antibiotic resistance gene downstream of the <italic>opvAB</italic> promoter. This construct may provide an experimental system to study bacterial heteroresistance (HR) to antibiotics under highly controlled conditions<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. HR is a phenotype where a bacterial isolate is characterized by the presence of a main susceptible population and a subpopulation with higher antibiotic resistance. Increasing evidence suggests that heteroresistance can lead to treatment failure<sup><xref ref-type="bibr" rid="CR12">12</xref>&#x02013;<xref ref-type="bibr" rid="CR17">17</xref></sup>. Yet, little is known regarding the characteristics of the heteroresistance phenotypes (i.e. the size of the resistant subpopulation or its level of resistance) that are linked to treatment failure. Animal experiments, where infections are started with bacterial cultures that carry an antibiotic resistance gene under control of the <italic>opvAB</italic> switch, would allow control of the frequency of the resistant subpopulation and determination of how different ratios of resistant:susceptible bacteria influence treatment outcome<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. Other potential uses of the <italic>opvAB</italic> switch in synthetic biology are discussed.<fig id="Fig1"><label>Figure 1</label><caption><p>Formation of Lac<sup>OFF</sup> and Lac<sup>ON</sup> subpopulations under <italic>opvAB</italic> control. (<bold>A</bold>) Diagram of the <italic>opvAB</italic> promoter and regulatory region, with the GATC sites outlined. (<bold>B</bold>) Diagram of the wild type <italic>opvAB</italic> operon and the P<sub><italic>opvAB</italic></sub>::<italic>lacZY</italic> construct. (<bold>C</bold>) Colonies formed on LB&#x02009;+&#x02009;X-gal by a <italic>S</italic>. <italic>enterica</italic> strain carrying the <italic>lacZY</italic> operon under the control of the wild type <italic>opvAB</italic> control region (SV9700, left), and by <italic>S</italic>. <italic>enterica</italic> strains carrying the <italic>lacZY</italic> operon under the control of mutant <italic>opvAB</italic> control regions (SV9701, P<sub><italic>opvAB</italic></sub> GATC<sub>1,2</sub>::<italic>lacZY</italic>::<italic>gfp</italic>, center; SV9702, P<sub><italic>opvAB</italic></sub> GATC-less::<italic>lacZY</italic>::<italic>gfp</italic>, right). (<bold>D</bold>) Flow cytometry analysis of P<sub><italic>opvAB</italic></sub>::<italic>lacZY</italic> expression in strains SV9700, SV9701 and SV9702. The sizes of Lac<sup>ON</sup> subpopulations are indicated. (<bold>E</bold>) Growth of strains SV9700, SV9701 and SV9702 in NCE-lactose. Error bars represent the standard error of the mean from 3 independent replicates. (<bold>F</bold>) Reversible formation of Lac<sup>OFF</sup> and Lac<sup>ON</sup> subpopulations under <italic>opvAB</italic> control in strain SV9700.</p></caption><graphic xlink:href="41598_2019_47650_Fig1_HTML" id="d29e582"/></fig></p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>Bistable expression of <italic>lacZY</italic> under <italic>opvAB</italic> transcriptional control</title><p id="Par5">The ability of the <italic>opvAB</italic> epigenetic switch to confer bistable expression to a heterologous locus was tested by engineering a strain that harbored the <italic>E</italic>. <italic>coli lacZY</italic> operon downstream of the <italic>opvAB</italic> promoter and its upstream regulatory region (P<sub><italic>opvAB</italic></sub> - Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1A,B</xref>). To avoid cell-to-cell heterogeneity associated with variations in plasmid copy number, the construct was engineered in the <italic>S</italic>. <italic>enterica</italic> chromosome. Construction involved replacement of the <italic>opvAB</italic> coding region with a promoterless <italic>lacZY</italic> operon, leaving the <italic>opvAB</italic> promoter and upstream regulatory region intact. The construct harbored the <italic>opvA</italic> ribosome binding site (RBS). Plating of the engineered strain on LB containing X-gal yielded Lac<sup>+</sup> (blue) and Lac<sup>&#x02212;</sup> (white) colonies, thus revealing bistable expression (Lac<sup>OFF</sup> or Lac<sup>ON</sup>) of the heterologous <italic>lacZY</italic> operon (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1C</xref>). Streaking of either Lac<sup>+</sup> or Lac<sup>&#x02212;</sup> colonies on X-gal agar yielded a mixture of Lac<sup>+</sup> and Lac<sup>&#x02212;</sup> colonies, thus indicating the occurrence of reversible bistability (&#x0201c;phase variation&#x0201d;) as previously described for the native <italic>opvAB</italic> locus<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>.</p><p id="Par6">Calculation of phase variation frequencies indicated a frequency of 1.1&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup>&#x02009;&#x000b1;&#x02009;0.3 per cell and generation for the OFF&#x02192;ON transition, and 3.4&#x02009;&#x000b1;&#x02009;0.1&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;2</sup> per cell and generation for the ON&#x02192;OFF transition. The 300-fold difference between switching rates was two-fold lower than in the native <italic>opvAB</italic> locus (OFF &#x02192; ON, 6.1&#x02009;&#x000b1;&#x02009;1.7&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup>; ON &#x02192; OFF 3.7&#x02009;&#x000b1;&#x02009;0.1&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;2</sup>; 600-fold difference between switching rates)<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. The increased size of the Lac<sup>ON</sup> subpopulation may result from multiple factors including potential differences in mRNA stability and codon usage constraints.</p><p id="Par7">Variants of the P<sub><italic>opvAB</italic></sub>::<italic>lacZY</italic> construct were engineered to further explore the ability of <italic>opvAB-</italic>driven transcription to confer bistable expression to a heterologous locus. One such variant involved the use of a mutant <italic>opvAB</italic> regulatory region lacking GATC sites 1 and 2 (GATC<sub>1,2</sub>), previously shown to increase the size of the OpvAB<sup>ON</sup> subpopulation<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. As expected, a higher proportion of Lac<sup>+</sup> colonies was detected (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1C</xref>). Another variant, used as control, lacked all <italic>opvAB</italic> GATC sites (GATC-less) and locked <italic>lacZY</italic> transcription in the ON state (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1C</xref>) as previously described for the native <italic>opvAB</italic> operon<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>.</p><p id="Par8">Variants carrying a green fluorescent protein gene (<italic>gfp</italic>) dowstream of the <italic>lacZY</italic> operon were also engineered, and assessment of subpopulation sizes by flow cytometry confirmed that the Lac<sup>ON</sup> subpopulation formed by the wild type <italic>opvAB</italic> switch was smaller than that formed by the GATC<sub>1,2</sub> variant (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1D</xref>). Furthermore, only cells in the Lac<sup>ON</sup> state were detected in the strain that harbored the GATC-less construct, and subpopulation formation was abolished as above (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1D</xref>).</p><p id="Par9">The ability of the <italic>opvAB</italic> switch to permit selection of one of the subpopulations was examined by testing the ability of strains carrying P<sub><italic>opvAB</italic></sub>::<italic>lacZY</italic>::<italic>gfp</italic> and P<sub><italic>opvAB</italic></sub> GATC<sub>1,2</sub>::<italic>lacZY</italic>::<italic>gfp</italic> constructs to grow in minimal medium with lactose as sole carbon source. As above, a strain carrying the GATC-less P<sub><italic>opvAB</italic></sub>::<italic>lacZY</italic>::<italic>gfp</italic> construct was included as a control. Assessment of the growth patterns of these strains revealed that the time required for culture saturation was dependent on the size of the Lac<sup>ON</sup> subpopulation present at the start of the culture (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1E</xref>). Reversibility of the Lac<sup>ON</sup> state was confirmed by growth on NCE-glucose (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1F</xref>).</p></sec><sec id="Sec4"><title>Bistable expression of the chimaeric <italic>opvAB</italic>::<italic>lacZY</italic> operon in a heterologous host, <italic>E</italic>. <italic>coli</italic></title><p id="Par10">The functionality of the <italic>opvAB</italic> switch in a heterologous host was tested in <italic>E</italic>. <italic>coli</italic>. For this purpose, the P<sub><italic>opvAB</italic></sub>::<italic>lacZY</italic>::<italic>gfp</italic> construct and its GATC<sub>1,2</sub> and GATC-less variants were introduced into the chromosome of <italic>E</italic>. <italic>coli</italic> DR3 (&#x00394;<italic>lacZY</italic>). Strains carrying the P<sub><italic>opvAB</italic></sub>::<italic>lacZY-gfp</italic> and P<sub><italic>opvAB</italic></sub> GATC<sub>1,2</sub>::<italic>lacZY</italic>::<italic>gfp</italic> constructs (DR22 and DR23, respectively) formed Lac<sup>+</sup> and Lac<sup>&#x02013;</sup> colonies on X-gal agar, and the number of Lac<sup>+</sup> colonies was higher in the strain carrying the P<sub><italic>opvAB</italic></sub> GATC<sub>1,2</sub>::<italic>lacZY</italic>::<italic>gfp</italic> construct. The strain carrying the GATC-less construct (DR24) formed Lac<sup>+</sup> colonies only (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2A</xref>). Flow cytometry assessment of GFP expression upon growth in LB confirmed the occurrence of subpopulations of Lac<sup>OFF</sup> and Lac<sup>ON</sup> cells in the strains carrying the P<sub><italic>opvAB</italic></sub>::<italic>lacZY</italic>::<italic>gfp</italic> and P<sub><italic>opvAB</italic></sub> GATC<sub>1,2</sub>::<italic>lacZY</italic>::<italic>gfp</italic> constructs but not in the strain carrying the GATC-less construct (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2B</xref>). As above, growth pattern assessment revealed that the time required for culture saturation was dependent on the initial size of the Lac<sup>ON</sup> subpopulation (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2C</xref>). Altogether, these observations indicated that the <italic>opvAB</italic> switch is functional in <italic>E</italic>. <italic>coli</italic>.<fig id="Fig2"><label>Figure 2</label><caption><p>Formation of Lac<sup>OFF</sup> and Lac<sup>ON</sup> subpopulations under <italic>opvAB</italic> control in <italic>E</italic>. <italic>coli</italic>. (<bold>A</bold>) Left: Colonies formed on LB&#x02009;+&#x02009;X-gal by an <italic>E</italic>. <italic>coli</italic> strain carrying the <italic>lacZY</italic> operon under the control of the wild type <italic>opvAB</italic> control region (strain DR22). Center and right: Colonies formed on LB&#x02009;+&#x02009;X-gal by <italic>E</italic>. <italic>coli</italic> strains carrying the <italic>lacZY</italic> operon under the control of mutant <italic>opvAB</italic> control regions (DR23 and DR24). (<bold>B</bold>) Flow cytometry analysis of P<sub><italic>opvAB</italic></sub>::<italic>lacZY</italic> expression in strains DR22, DR23 and DR24. The sizes of Lac<sup>ON</sup> subpopulations are indicated. (<bold>C</bold>) Growth of strains DR22, DR23 and DR24 in NCE-lactose. Error bars represent the standard error of the mean from 3 independent replicates.</p></caption><graphic xlink:href="41598_2019_47650_Fig2_HTML" id="d29e1045"/></fig></p></sec><sec id="Sec5"><title>Bistable expression of antibiotic resistance genes under <italic>opvAB</italic> control</title><p id="Par11">An additional test of the ability of the <italic>opvAB</italic> bistable switch to generate bacterial subpopulations was performed by cloning antibiotic resistance genes downstream of the <italic>opvAB</italic> promoter in the <italic>S</italic>. <italic>enterica</italic> chromosome. The antibiotic resistance genes chosen for these experiments were <italic>aac3-Ib</italic> (henceforth, <italic>aac3)</italic> and <italic>aac(6</italic>&#x02032;<italic>)-Ib-cr</italic> (henceforth, <italic>aac6</italic>), which encode aminoglycoside acetyl transferases<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>, and <italic>bla</italic><sub>CTX-M-15</sub> (henceforth, <italic>ctxM)</italic>, which encodes an extended-spectrum &#x003b2;-lactamase<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. In these constructs, the native ribosome binding sites were replaced with a stronger RBS, named BI<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> to adjust the sensitivity of the switch to a level that could permit unambiguous detection of the antibiotic resistance phenotype under study, thus facilitating discrimination between OFF and ON cells. Experiments with strains carrying P<sub><italic>opvAB</italic></sub>::<italic>aac6</italic>::<italic>gfp</italic> and P<sub><italic>opvAB</italic></sub>::<italic>ctxM</italic>::<italic>gfp</italic> fusions (strains SV9703 and SV9706, respectively) yielded bacterial subpopulations resistant to kanamycin and to cefotaxime, respectively (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3A</xref>). Controls using strains that constitutively expressed&#x000a0;<italic>aac6</italic> and <italic>ctxM</italic> (SV9705 and SV9707, respectively) showed that the concentrations of antibiotics used permitted growth (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3A</xref>). The wild type strain ATCC 14028 failed to grow under such conditions, confirming that the concentrations of antibiotics used were bactericidal.<fig id="Fig3"><label>Figure 3</label><caption><p>(<bold>A</bold>) Growth of strains SV9703 (P<sub><italic>opvAB</italic></sub><italic>::aac6</italic>::<italic>gfp</italic>), SV9705 (P<sub><italic>opvAB</italic></sub> GATC-less::<italic>aac6</italic>::<italic>gfp</italic>) SV9706 (P<sub><italic>opvAB</italic></sub>::<italic>ctxM</italic>::<italic>gfp</italic><bold>)</bold> and SV9707 (P<sub><italic>opvAB</italic></sub> GATC-less::<italic>ctxM</italic>::<italic>gfp</italic>) in LB and in LB&#x02009;+&#x02009;antibiotic (kanamycin and cefotaxime, respectively). (<bold>B</bold>) Left: reversibility of formation of Km<sup>s</sup> and Km<sup>r</sup> subpopulations under <italic>opvAB</italic> control. Right: reversibility of formation of CtxM<sup>s</sup> and CtxM<sup>r</sup> subpopulations under <italic>opvAB</italic> control.</p></caption><graphic xlink:href="41598_2019_47650_Fig3_HTML" id="d29e1213"/></fig></p><p id="Par12">Flow cytometry analysis confirmed that growth in the presence of kanamycin and cefotaxime was a consequence of subpopulation selection (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3B</xref>), excluding the idea that growth might result from selection of mutants present in the inoculum. This conclusion was further strengthened by the observation that growth in LB restored the initial sizes of ON and OFF subpopulations (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3B</xref>).</p></sec><sec id="Sec6"><title>Use of the OpvAB synthetic switch in generating antibiotic heteroresistance</title><p id="Par13">As a proof of concept, we examined the utility of the OpvAB switch to address antibiotic heteroresistance and the question of what proportions of resistant subpopulations might lead to clinical treatment failure. Specifically, we tested whether the OpvAB switch could generate, in a susceptible main population, defined subpopulations of cells with increased antibiotic resistance. For this purpose, we used a <italic>S</italic>. <italic>enterica</italic> strain harboring a P<sub><italic>opvAB</italic></sub>::BI-<italic>aac3</italic>::<italic>gfp</italic> construct (SV9776). Expression of <italic>aac3</italic> (Aac3<sup>ON</sup>) leads to kanamycin resistance (Km<sup>r</sup>). The frequency of Km<sup>r</sup> cells formed by a pure culture of SV9776 was 1&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;2</sup> (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4A</xref>), similar to the frequency of ON cells detected when <italic>gfp</italic> was cloned behind the <italic>opvAB</italic> promoter (1.1%: Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1D</xref>). To obtain smaller subpopulation sizes without altering other phenotypic traits of the strain, SV9776 was mixed with an isogenic strain that expressed P<sub><italic>opvAB</italic></sub>::<italic>gfp</italic> (SV9777) and did not produce any Km<sup>r</sup> resistant subpopulation. Mixtures of cells were prepared from overnight cultures in Mueller-Hinton (MH) broth at proportions 1:10, 1:100, 1:1,000, 1:10,000 and 0:1. Population analysis profile (PAP) tests were then performed by plating on MH agar containing increasing concentrations of kanamycin. After overnight incubation, the number of resistant cells and total number of cells were determined to allow calculation of the fraction of resistant cells. The numbers of Km<sup>r</sup> colonies detected in the PAP tests were proportional to the amounts of the Aac3<sup>ON</sup> subpopulations present in each mixture, and ranged from 1&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;2</sup> to 1&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup> (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4A</xref>). Epsilometer tests (Etests) further confirmed that the size of the Km<sup>r</sup> subpopulation decreased in a manner proportional to dilution (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4B</xref>).<fig id="Fig4"><label>Figure 4</label><caption><p>The <italic>opvAB</italic> switch as a tool for the study of antibiotic heteroresistance. (<bold>A</bold>) Population analysis profile (PAP) tests of kanamycin resistance in strains SV9776 and SV9777 (carrying P<sub><italic>opvAB</italic></sub>::BI-<italic>aac3</italic>::<italic>gfp</italic> and P<sub><italic>opvAB</italic></sub>::<italic>gfp</italic> constructs, respectively). The proportions indicated are those of the mixtures of SV9776:SV9777. Error bars represent standard deviations of three independent mixtures. (<bold>B</bold>) Epsilometer tests (Etests) performed on the same mixtures of SV9776 and SV9777. The kanamycin resistant subpopulations appear as low-density lawns (mixtures 1:0 and 1:10) or as isolated colonies growing at kanamycin concentrations above the MIC of the main susceptible population ([Km]&#x02009;&#x0003e;&#x02009;1&#x02009;mg/L - mixtures 1:10 to 1:10,000). No kanamycin resistant subpopulation exists for the 0:1 mixture.</p></caption><graphic xlink:href="41598_2019_47650_Fig4_HTML" id="d29e1340"/></fig></p></sec></sec><sec id="Sec7" sec-type="discussion"><title>Discussion</title><p id="Par14">In its native host, the <italic>opvAB</italic> operon undergoes bistable transcription, which generates OpvAB<sup>ON</sup> and OpvAB<sup>OFF</sup> subpopulations<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. Bistability is reversible (&#x0201c;phase-variable&#x0201d;) and the switching rate is skewed to OFF in the wild type<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup>. In this study, we show that a 689&#x02009;bp DNA fragment containing the <italic>opvAB</italic> promoter and the <italic>opvAB</italic> upstream activating sequence (UAS) confers bistability to genes cloned downstream. For instance, an engineered P<sub><italic>opvAB</italic></sub>::<italic>lacZY</italic> operon produces Lac<sup>OFF</sup> and Lac<sup>ON</sup> subpopulations (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1C</xref>), and addition of a <italic>gfp</italic> reporter gene permits discrimination of Lac<sup>OFF</sup> and Lac<sup>ON</sup> cells by flow cytometry (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1D</xref>). Utilization of L-lactose sustains growth of Lac<sup>ON</sup> cells (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1E</xref>), thereby producing increased fluorescence. However, because the <italic>opvAB</italic> switch is reversible, in the absence of L-lactose the system slowly returns to its initial state, with a strong predominance of Lac<sup>OFF</sup> cells (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1F</xref>).</p><p id="Par15">The fact that the <italic>opvAB</italic> cassette is functional in <italic>E</italic>. <italic>coli</italic> (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>) suggests that the switch can be used to generate bistability in other heterologous hosts. However, the need of both Dam methylation and OxyR may be an obvious limitation. Aside from this caveat, the versatility of the switch is reinforced by an additional example of subpopulation formation presented in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>: P<sub><italic>opvAB</italic></sub>-driven bistable expression of kanamycin and cefotaxime resistance genes permitted selection of antibiotic-resistant subpopulations in a reversible fashion.</p><p id="Par16">Introduction of mutations in the upstream regulatory region of the native <italic>opvAB</italic> operon alters the switching rate, yielding OpvAB<sup>ON</sup> and OpvAB<sup>OFF</sup> subpopulation sizes that are different from those of the wild type<sup><xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup>. Hence, variants of the <italic>opvAB</italic> switch can be engineered to modulate subpopulation sizes at will. For instance, a variant (GATC<sub>1,2</sub>) that lacks two of the four GATC sites present in the wild type increases the initial size of the ON subpopulation (Figs&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> and <xref rid="Fig2" ref-type="fig">2</xref>). Additional UAS variants that yield subpopulations of different sizes have been described<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>, and their use may allow choice of other switching frequencies. Modification of the ribosome-binding site of genes under <italic>P</italic><sub><italic>opvAB</italic></sub> control can also contribute to adjust the sensitivity of the switch, facilitating detection of the phenotype under study. For instance, use of the BI ribosome binding site<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> permitted unambiguous detection of <italic>aac3</italic>-mediated kanamycin resistance, thereby facilitating discrimination of Km<sup>r</sup> cells (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>).</p><p id="Par17">As a proof of concept, we have used the <italic>opvAB</italic> switch to produce antibiotic-resistant and antibiotic-susceptible bacterial subpopulations of predetermined sizes. The aim of these experiments was to mimic under laboratory conditions bacterial heteroresistance to antibiotics, a phenomenon where small subpopulations of cells show higher antibiotic resistance than the main population<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. Heteroresistance is difficult to detect and study in clinical samples<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>, and accurate assessment of the frequencies of subpopulation formation and of their antibiotic resistance levels may improve our understanding of heteroresistance as a cause of clinical treatment failure<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>. Experiments shown in Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref> provide evidence that subpopulation formation under <italic>opvAB</italic> control allows accurate modulation of the number of resistant cells present in a population. In principle, the method should be applicable to any antibiotic resistance gene. Because we were able to specifically vary the frequency of resistant bacteria in the population, this approach provides a proof of concept to study how different frequencies of resistant subpopulations may affect the outcome of antimicrobial treatment <italic>in vivo</italic> (e. g., in a murine model). In theory, mixing constitutively resistant and susceptible strains that are otherwise isogenic would also lead to bacterial cultures with pre-defined amounts of resistant bacteria. However, to reach specific frequencies of resistant bacteria our OpvAB-based approach requires mixing bacteria at frequencies 100-fold lower (e. g., to reach frequencies of 1&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup> Km<sup>r</sup> resistant bacteria, the P<sub>opvAB</sub>::BI-<italic>aac3</italic> strain was mixed at a frequency of 1&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup>). Thus, an advantage of our <italic>opvAB</italic> switch-based approach is that it can be expected to be less affected by infection bottlenecks that could otherwise eliminate very small subpopulations of bacteria present in the inoculum<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. For example, one such bottleneck is observed during cecum colonization by <italic>Salmonella</italic> in mice 2&#x02013;4 days after oral infection, and is dependent on the inflammatory response induced by <italic>S</italic>. <italic>enterica</italic> invading epithelial cells<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR23">23</xref></sup>.</p><p id="Par18">Additional applications of the <italic>opvAB</italic> switch can be envisaged, including the design of bistable biosensors. For instance, a strain harboring an P<sub><italic>opvAB</italic></sub>::<italic>gfp</italic> fusion might be useful to detect bacteriophages in environmental samples using flow cytometry<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>, and to identify DNA methylation inhibitors in screens for novel antimicrobial drugs<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR27">27</xref></sup>. Sensors of this kind can be expected to be selective as growth will occur under specific circumstances only. Furthermore, use of fluorescence to monitor growth of ON cells can be expected to be sensitive and rapid, and constitutive expression may contribute to robustness, avoiding the problem of instability of transcription-based gene circuits<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. Besides biosensor design, formation of phenotypic subpopulations under epigenetic control might have additional applications in synthetic biology: for instance, division&#x000a0;of labour between subpopulations performing distinct segments of a catabolic pathway might optimize biodegradation processes<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>.</p></sec><sec id="Sec8"><title>Methods</title><sec id="Sec9"><title>Strains and strain construction</title><p id="Par19">Strains of <italic>Salmonella enterica</italic> serovar Typhimurium and <italic>Escherichia coli</italic> used in this study are listed in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. Strain construction by targeted gene disruption was achieved using plasmids pKD3, pKD4 or pKD13 as templates to generate PCR products for homologous recombination<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. Antibiotic resistance cassettes introduced during strain construction were excised by recombination with plasmid pCP20<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. Primers used in strain construction are shown in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. For the construction of translational <italic>lac</italic> fusions on the <italic>S</italic>. <italic>enterica</italic> chromosome, FRT sites generated by excision of Km<sup>r</sup> cassettes were used to integrate plasmid pCE40<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. For construction of fluorescent fusions, a DNA fragment containing a promoterless green fluorescent protein (<italic>gfp</italic>) gene and a chloramphenicol resistance cassette was PCR-amplified from plasmid pZEP07<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>, and the resulting PCR product was integrated into the chromosome of each strain. For construction of strains that carry antibiotic resistance genes under P<sub><italic>opvAB</italic></sub> control, a counterselectable cassette containing <italic>sacB</italic> and Ap<sup>R</sup> genes was amplified from strain DA52596 using the oligos opvAB-ampsacB-F and ampsacB-gfp-R. The PCR product was integrated into the chromosome of SV6727 and SV6729 respectively, generating the intermediate strains MN441 and MN442, respectively. Antibiotic resistance genes were introduced into these strains by targeted gene disruption<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>, and transformants in which the ampicillin-<italic>sacB</italic> cassette had been excised were selected on minimal plates containing&#x000a0;sucrose.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Bacterial strains and plasmids.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Strain</th><th>Genotype</th></tr></thead><tbody><tr><td>ATCC 14028<sup>a</sup></td><td>Wild type</td></tr><tr><td>MG1655<sup>b</sup></td><td>Wild type</td></tr><tr><td>CC118 &#x003bb; <italic>pir</italic><sup>b</sup></td><td><italic>phoA20 thi-1 rspE rpoB argE(Am) recA1 (</italic>lambda <italic>pir</italic>)</td></tr><tr><td>S17 &#x003bb; <italic>pir</italic><sup>b</sup></td><td><italic>recA pro hsdR</italic> RP4-2-Tc::Mu-Km::Tn7 (lambda <italic>pir</italic>)</td></tr><tr><td>DA52596<sup>a</sup></td><td><italic>&#x02206;(CRISPR1-cas1)::spc &#x02206;(CRISPR2)::amp-sacB / pSim5-tet</italic></td></tr><tr><td>SV6727<sup>a</sup></td><td><italic>opvAB::gfp</italic></td></tr><tr><td>SV6729<sup>a</sup></td><td><italic>opvAB</italic> GATC-less::<italic>gfp</italic></td></tr><tr><td>SV8499<sup>a</sup></td><td><italic>P</italic><sub><italic>opvAB</italic></sub>::<italic>lacZY</italic></td></tr><tr><td>SV9700<sup>a</sup></td><td><italic>P</italic><sub><italic>opvAB</italic></sub>::<italic>lacZY</italic>::<italic>gfp</italic></td></tr><tr><td>SV9701<sup>a</sup></td><td>P<sub><italic>opvAB</italic></sub> GATC<sub>1,2</sub>::<italic>lacZY</italic>::<italic>gfp</italic></td></tr><tr><td>SV9702<sup>a</sup></td><td>P<sub><italic>opvAB</italic></sub> GATC-less::<italic>lacZY</italic>::<italic>gfp</italic></td></tr><tr><td>SV9703<sup>a</sup></td><td>P<sub><italic>opvAB</italic></sub>::BI-<italic>aac6</italic>::<italic>gfp</italic></td></tr><tr><td>SV9705<sup>a</sup></td><td>P<sub><italic>opvAB</italic></sub> GATC-less::BI-<italic>aac6</italic>::<italic>gfp</italic></td></tr><tr><td>SV9706<sup>a</sup></td><td>P<sub><italic>opvAB</italic></sub>::BI-<italic>ctxm</italic>::<italic>gfp</italic></td></tr><tr><td>SV9707<sup>a</sup></td><td>P<sub><italic>opvAB</italic></sub> GATC-less::BI-<italic>ctxm::gfp</italic></td></tr><tr><td>DR3<sup>a</sup></td><td>&#x02206;<italic>lacZY</italic></td></tr><tr><td>DR22<sup>b</sup></td><td>&#x02206;<italic>lacZY</italic> P<sub><italic>opvAB</italic></sub>::<italic>lacZY</italic>::<italic>gfp</italic></td></tr><tr><td>DR23<sup>b</sup></td><td>&#x02206;<italic>lacZY</italic> P<sub><italic>opvAB</italic></sub> GATC<sub><italic>1</italic>,<italic>2</italic></sub>::<italic>lacZY::gfp</italic></td></tr><tr><td>DR24<sup>b</sup></td><td>&#x02206;<italic>lacZY</italic> P<sub><italic>opvAB</italic></sub> GATC-less::<italic>lacZY</italic>::<italic>gfp</italic></td></tr><tr><td>MN441<sup>a</sup></td><td>P<sub><italic>opvAB</italic></sub>::<italic>bla-sacB</italic>::<italic>gfp</italic></td></tr><tr><td>MN442<sup>a</sup></td><td>P<sub><italic>opvAB</italic></sub> GATC-less::<italic>bla-sacB::gfp</italic></td></tr><tr><td>SV9776<sup>a</sup></td><td>P<sub><italic>opvAB</italic></sub>::BI-<italic>aac3</italic>::<italic>gfp</italic></td></tr><tr><td>SV9777<sup>a</sup></td><td>P<sub><italic>opvAB</italic></sub>::<italic>gfp</italic></td></tr><tr><td>Plasmid</td><td>Description</td></tr><tr><td>pIZ2224</td><td>pDMS197::P<sub><italic>opvAB</italic></sub> GATC<sub><italic>1</italic>,<italic>2</italic></sub></td></tr><tr><td>pIZ2234</td><td>pDMS197::P<sub><italic>opvAB</italic></sub> GATC-less</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup><italic>S. enterica</italic>; <sup>b</sup><italic>E</italic>. <italic>coli</italic>.</p></table-wrap-foot></table-wrap><table-wrap id="Tab2"><label>Table 2</label><caption><p>Oligonucleotides.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Name</th><th>Sequence (5&#x02032;-3&#x02032;)</th><th>Use</th></tr></thead><tbody><tr><td>Operonlac-PS1</td><td>ATGATAGCGCCCGGAAGAGAGTCAATTCAGGGTGGTGAATGTGTAGGCTGGAGATGCTTC</td><td rowspan="2">Amplification of Km<sup>r</sup> gene from pKD4</td></tr><tr><td>Operonlac-PS2</td><td>TAGGCCTGATAAGCGCAGCGTATCAGGCAATTTTTATAATCATATGAATAT</td></tr><tr><td>MG1655-opvA</td><td>ATGATAGCGCCCGGAAGAGAGTCAATTCAGGGTGGTGAATTCATTTGGTTATAAATAGAG</td><td rowspan="2">Amplification of the <italic>opvAB</italic> operon (wild type and variants)</td></tr><tr><td>MG1655-opvB</td><td>TAGGCCTGATAAGCGCAGCGTATCAGGCAATTTTTATAATGAGTTTATCTCTGCGCAATGT</td></tr><tr><td>pCE40lacY-gfp-5</td><td>GCTTTCCCTGCTGCGTCGTCAGGTGAATGAAGTCGCTTAATAAGAAGGAGATATACATATGAG</td><td rowspan="2">Amplification of <italic>gfp</italic> and Cm<sup>r</sup> genes from pZEP07</td></tr><tr><td>pCE40-km-3</td><td>AAACTGTCTGCTTACATAAACAGTAATACAAGGGGTGTTTTATCACTTATTACAGGCGTA</td></tr><tr><td>opvA-aac6-F</td><td>TCTTATGAAGAAATATACGTTCGCTAAGGAGGTTTTCTAATGAGCAACGCAAAAACAAAG</td><td rowspan="2">Amplification of the <italic>aac(6</italic>&#x02032;<italic>)-Ib-cr</italic> gene</td></tr><tr><td>aac6-gfp-R</td><td>AAAGTTCTTCTCCTTTACTCATATGTATATCTCCTTCTTATTAGGCATGACTGCGTGTTC</td></tr><tr><td>opvA-ctxm-F</td><td>TCTTATGAAGAAATATACGTTCGCTAAGGAGGTTTTCTAATGGTTAAAAAATCACTGCG</td><td rowspan="2">Amplification of the <italic>bla</italic><sub><italic>CTX-M-15</italic></sub> gene</td></tr><tr><td>ctxm-gfp-R</td><td>AAAGTTCTTCTCCTTTACTCATATGTATATCTCCTTCTTATTACAAACCGTCGGTGACGA</td></tr><tr><td>PopvAB-aac3-F</td><td>ATCTTATGAAGAAATATACGTTCGCTAAGGAGGTTTTCTAATGCATACGCGGAAGGCAATAAC</td><td rowspan="2">Amplification of the <italic>aac3-Ib</italic> gene</td></tr><tr><td>GFP-aac3-R</td><td>GAAAAGTTCTTCTCCTTTACTCATATGTATATCTCCTTCTTACTAACCGGAAGGCTCGCAAG</td></tr><tr><td>opvAB-ampsacB-F</td><td>TCTTATGTGTGGGTTTTATCTTATGAAGAAATATACGTTCGCTAAGGAGGTTTTCTAATGTAGGCTGGAGCTGCTTC</td><td rowspan="2">Amplification of the <italic>bla-sacB</italic> cassette</td></tr><tr><td>ampsacB-gfp-R</td><td>AAAGTTCTTCTCCTTTACTCATATGTATATCTCCTTCTTACATATGAATATCCTCCTTAGTTCC</td></tr></tbody></table></table-wrap></p><p id="Par20">Transductional crosses using phage P22 HT 105/1 <italic>int201</italic><sup><xref ref-type="bibr" rid="CR33">33</xref></sup> were used for transfer of chromosomal markers between <italic>S</italic>. <italic>enterica</italic> strains<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. To obtain phage-free isolates, transductants were purified by streaking on green plates<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. Phage sensitivity was tested by cross-streaking with P22 H5.</p><p id="Par21">Directed construction of point mutations was achieved using the QuikChange<sup>&#x000ae;</sup> Site-Directed Mutagenesis Kit (Stratagene) using the suicide plasmid pDMS197<sup><xref ref-type="bibr" rid="CR36">36</xref></sup> and propagated in <italic>E</italic>. <italic>coli</italic> CC118 &#x003bb; <italic>pir</italic>. Plasmids derived from pMDS197 (pIZ2224 and pIZ2234) were transformed into <italic>E</italic>. <italic>coli</italic> S17-1 &#x003bb; <italic>pir</italic>. The resulting strains were used as donors in matings with <italic>S</italic>. <italic>enterica</italic> SV9700, selecting tetracycline-resistant transconjugants on minimal plates. One transductant from each mating was propagated as strains SV9701 and SV9702.</p></sec><sec id="Sec10"><title>Culture media and growth conditions</title><p id="Par22">Bertani&#x02019;s lysogeny broth (LB)<sup><xref ref-type="bibr" rid="CR37">37</xref></sup> was used as standard liquid medium. Solid LB contained agar at 1.5% final concentration. Mueller-Hinton (MH) broth and agar<sup><xref ref-type="bibr" rid="CR38">38</xref></sup> was used in antibiotic susceptibility tests. Green plates<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> contained methyl blue (Sigma-Aldrich) instead of aniline blue. The indicador of &#x003b2;-galactosidase activity in plate tests was 5-bromo-4-chloro-3indolyl-&#x003b2;-D-galactopyranoside (X-gal; Sigma-Aldrich, 40&#x02009;mg/L). No-carbon essential (NCE) medium<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>, supplemented with either glucose (0, 2%) or lactose (0, 2%), was used as minimal medium. When necessary, antibiotics were added to the culture medium at following concentrations: ampicillin (100&#x02009;mg/L), kanamycin (50&#x02009;mg/L), chloramphenicol (25&#x02009;mg/L), and cefotaxamine (40&#x02009;mg/L).</p></sec><sec id="Sec11"><title>Flow cytometry</title><p id="Par23">Bacterial cultures were grown in LB at 37&#x02009;&#x000b0;C until exponential phase (O.D.<sub>600</sub> 0.3). Cells were then diluted in PBS to a final concentration of approximately 10<sup>7</sup>/ml. Data acquisition and analysis were performed using a Cytomics FC500-MPL cytometer (Beckman Coulter). Data were collected for 100 000 events per sample, and were analyzed with CXP and FlowJo8.7 software. Data are represented by a dot plot (forward scatter [cell size] versus fluorescence intensity.</p></sec><sec id="Sec12"><title>Growth curves</title><p id="Par24">Plates were incubated at 37&#x02009;&#x000b0;C with shaking on an automated microplate reader (Synergy HTX Multi-Mode Reader, Biotek), and the absorbance at 600&#x02009;nm for each well was measured every 30&#x02009;min. Each sample was assayed by triplicate. Growth of SV9700, SV9701, SV9703, DR22, DR23 and DR24 strains was monitored in NCE-lactose and NCE-glucose. Growth of SV9704, SV9705, SV9706, SV9707 was monitored in LB broth with and without antibiotics.</p></sec><sec id="Sec13"><title>Calculation of phase variation rates</title><p id="Par25">Phase variation rates were estimated as described by Eisenstein<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. Briefly, a strain harboring a <italic>lacZY</italic> fusion was plated on LB&#x02009;+&#x02009;X-gal and colonies displaying an ON or OFF phenotype after 16&#x02009;h growth at 37&#x02009;&#x000b0;C were selected, resuspended in PBS and re-spread on fresh LB&#x02009;+&#x02009;X-gal plates. Phase variation frequencies were calculated using the formula <italic>(M/N)/g</italic> where <italic>M</italic> is the number of cells that underwent phase variation, <italic>N</italic> the total number of cells, and <italic>g</italic> the total number of generations that gave rise to the colony.</p></sec><sec id="Sec14"><title>Epsilometer (E) tests of antibiotic resistance</title><p id="Par26">Etest strips were purchased from bioM&#x000e9;rieux. Mixtures of overnight cultures of bacteria grown in MH broth were diluted 1:25 in phosphate buffered saline (PBS) to reach cell densities of 0.5 MacFarland or about 1.5&#x02009;&#x000d7;&#x02009;10<sup>8</sup> CFU/mL. Bacteria were plated onto MH agar plates using sterile cotton swabs dipped in the cell suspensions, and a Etest strip was applied on top. Plates were incubated 18&#x02009;h at 37&#x02009;&#x000b0;C before reading the results and taking pictures.</p></sec><sec id="Sec15"><title>Population analysis profile (PAP) tests</title><p id="Par27">PAP tests were performed on MH agar plates supplemented with increasing amounts of kanamycin (Sigma Aldrich) as described previously<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>. Five &#x000b5;l of overnight cultures in MH broth (containing approx. 3&#x02009;&#x000d7;&#x02009;10<sup>9</sup> cells/ml) and serial dilutions (down to 10<sup>&#x02212;6</sup>) were spread on MH plates containing no antibiotics (for total CFU determination) or different concentrations of kanamycin. The plates were incubated overnight and the colonies were counted. Colony numbers were plotted in a graph to determine if the PAP fulfilled the criteria for heteroresistance (at least 8-fold difference in antibiotic concentration between the highest non-inhibitory concentration and the highest inhibitory concentration).</p><p id="Par28">To prepare mixtures of resistant and susceptible cells, three isolated colonies of SV9776 (P<sub><italic>opvAB</italic></sub>::BI-<italic>aac3</italic>::<italic>gfp</italic>, kanamycin resistant in the ON state) and SV9777 (P<sub><italic>opvAB</italic></sub>::<italic>gfp</italic>, always kanamycin susceptible) were grown overnight in 2&#x02009;mL MH broth at 37&#x02009;&#x000b0;C under shaking. Pure cultures of each overnight or three independent sets of SV9776:SV9777 mixtures at proportions ranging from 1:10 to 1:10,000 were used for PAP tests.</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p><bold>Change history</bold></p><p>11/25/2019</p><p>An amendment to this paper has been published and can be accessed via a link at the top of the paper.</p></fn></fn-group><ack><title>Acknowledgements</title><p>This study was supported by grant BIO2016-75235-P from the Ministerio de Ciencia, Innovaci&#x000f3;n y Universidades of Spain (to JC) and the Swedish Research Council grant 2017-01527 (to DIA). We are grateful to Elena Puerta-Fern&#x000e1;ndez for advice and discussions, and to Modesto Carballo, Laura Navarro, and Cristina Reyes of the Servicio de Biolog&#x000ed;a, CITIUS, Universidad de Sevilla, for help with experiments performed at the facility.</p></ack><notes notes-type="author-contribution"><title>Author Contributions</title><p>D.R.O., H.N., M.A.S. and I.C. carried out the experiments; D.R.O., H.N., M.A.S., I.C., D.I.A. and J.C. designed the experiments and interpreted results; D.R.O., H.N., D.I.A. and J.C. wrote the manuscript.</p></notes><notes notes-type="COI-statement"><title>Competing Interests</title><p id="Par29">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradley</surname><given-names>RW</given-names></name><name><surname>Buck</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name></person-group><article-title>Tools and principles for microbial gene circuit engineering</article-title><source>J Mol Biol</source><year>2016</year><volume>428</volume><fpage>862</fpage><lpage>888</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2015.10.004</pub-id><pub-id pub-id-type="pmid">26463592</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Park</surname><given-names>M</given-names></name><name><surname>Tsai</surname><given-names>SL</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name></person-group><article-title>Microbial biosensors: engineered microorganisms as the sensing machinery</article-title><source>Sensors (Basel)</source><year>2013</year><fpage>5777</fpage><lpage>5795</lpage></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engstrom</surname><given-names>MD</given-names></name><name><surname>Pfleger</surname><given-names>BF</given-names></name></person-group><article-title>Transcription control engineering and applications in synthetic biology</article-title><source>Synth Syst Biotechnol</source><year>2017</year><volume>2</volume><fpage>176</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1016/j.synbio.2017.09.003</pub-id><pub-id pub-id-type="pmid">29318198</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kremers</surname><given-names>GJ</given-names></name><name><surname>Gilbert</surname><given-names>SG</given-names></name><name><surname>Cranfill</surname><given-names>PJ</given-names></name><name><surname>Davidson</surname><given-names>MW</given-names></name><name><surname>Piston</surname><given-names>DW</given-names></name></person-group><article-title>Fluorescent proteins at a glance</article-title><source>J Cell Sci</source><year>2011</year><volume>124</volume><fpage>157</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1242/jcs.072744</pub-id><pub-id pub-id-type="pmid">21187342</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huertas</surname><given-names>CS</given-names></name><etal/></person-group><article-title>Label-free DNA-methylation detection by direct ds-DNA fragment screening using poly-purine hairpins</article-title><source>Biosens Bioelectron</source><year>2018</year><volume>120</volume><fpage>47</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.bios.2018.08.027</pub-id><pub-id pub-id-type="pmid">30144645</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamatsugu</surname><given-names>K</given-names></name><name><surname>Kawashima</surname><given-names>SA</given-names></name><name><surname>Kanai</surname><given-names>M</given-names></name></person-group><article-title>Leading approaches in synthetic epigenetics for novel therapeutic strategies</article-title><source>Curr Opin Chem Biol</source><year>2018</year><volume>46</volume><fpage>10</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.cbpa.2018.03.011</pub-id><pub-id pub-id-type="pmid">29631088</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damayanti</surname><given-names>NP</given-names></name><name><surname>Buno</surname><given-names>K</given-names></name><name><surname>Voytik Harbin</surname><given-names>SL</given-names></name><name><surname>Irudayaraj</surname><given-names>JMK</given-names></name></person-group><article-title>Epigenetic process monitoring in live cultures with peptide biosensors</article-title><source>ACS Sens</source><year>2019</year><volume>4</volume><fpage>562</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1021/acssensors.8b01134</pub-id><pub-id pub-id-type="pmid">30714727</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname><given-names>JAH</given-names></name><name><surname>Mohrle</surname><given-names>R</given-names></name><name><surname>Jeltsch</surname><given-names>A</given-names></name></person-group><article-title>Design of synthetic epigenetic circuits featuring memory effects and reversible switching based on DNA methylation</article-title><source>Nat Commun</source><year>2017</year><volume>8</volume><fpage>15336</fpage><pub-id pub-id-type="doi">10.1038/ncomms15336</pub-id><pub-id pub-id-type="pmid">28537256</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cota</surname><given-names>I</given-names></name><name><surname>Blanc-Potard</surname><given-names>AB</given-names></name><name><surname>Casadesus</surname><given-names>J</given-names></name></person-group><article-title>STM2209-STM2208 (opvAB): a phase variation locus of Salmonella enterica involved in control of O-antigen chain length</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>e36863</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0036863</pub-id><pub-id pub-id-type="pmid">22606300</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cota</surname><given-names>I</given-names></name><etal/></person-group><article-title>OxyR-dependent formation of DNA methylation patterns in OpvABOFF and OpvABON cell lineages of Salmonella enterica</article-title><source>Nucleic Acids Res</source><year>2016</year><volume>44</volume><fpage>3595</fpage><lpage>3609</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv1483</pub-id><pub-id pub-id-type="pmid">26687718</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cota</surname><given-names>I</given-names></name><etal/></person-group><article-title>Epigenetic control of Salmonella enterica O-antigen chain length: a tradeoff between virulence and bacteriophage resistance</article-title><source>PLoS Genet</source><year>2015</year><volume>11</volume><fpage>e1005667</fpage><pub-id pub-id-type="doi">10.1371/journal.pgen.1005667</pub-id><pub-id pub-id-type="pmid">26583926</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Halfawy</surname><given-names>OM</given-names></name><name><surname>Valvano</surname><given-names>MA</given-names></name></person-group><article-title>Antimicrobial heteroresistance: an emerging field in need of clarity</article-title><source>Clin Microbiol Rev</source><year>2016</year><volume>28</volume><fpage>191</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1128/CMR.00058-14</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Band</surname><given-names>VI</given-names></name><etal/></person-group><article-title>Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae</article-title><source>Nat Microbiol</source><year>2016</year><volume>1</volume><fpage>16053</fpage><pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.53</pub-id><pub-id pub-id-type="pmid">27572838</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Band</surname><given-names>VI</given-names></name><etal/></person-group><article-title>Carbapenem-resistant Klebsiella pneumoniae exhibiting clinically undetected colistin heteroresistance leads to treatment failure in a murine model of infection</article-title><source>mBio</source><year>2018</year><volume>9</volume><fpage>e02448</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1128/mBio.02448-17</pub-id><pub-id pub-id-type="pmid">29511071</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicoloff</surname><given-names>H</given-names></name><name><surname>Hjort</surname><given-names>K</given-names></name><name><surname>Levin</surname><given-names>BR</given-names></name><name><surname>Andersson</surname><given-names>DI</given-names></name></person-group><article-title>The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification</article-title><source>Nat Microbiol</source><year>2019</year><volume>4</volume><fpage>504</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1038/s41564-018-0342-0</pub-id><pub-id pub-id-type="pmid">30742072</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hjort</surname><given-names>K</given-names></name><name><surname>Nicoloff</surname><given-names>H</given-names></name><name><surname>Andersson</surname><given-names>DI</given-names></name></person-group><article-title>Unstable tandem gene amplification generates heteroresistance (variation in resistance within a population) to colistin in Salmonella enterica</article-title><source>Mol Microbiol</source><year>2019</year><volume>102</volume><fpage>274</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1111/mmi.13459</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname><given-names>DI</given-names></name><name><surname>Nicoloff</surname><given-names>H</given-names></name><name><surname>Hjort</surname><given-names>K</given-names></name></person-group><article-title>Mechanisms and clinical relevance of bacterial heteroresistance</article-title><source>Nat Rev Microbiol</source><year>2019</year><volume>17</volume><fpage>479</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1038/s41579-019-0218-1</pub-id><pub-id pub-id-type="pmid">31235888</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubois</surname><given-names>V</given-names></name><etal/></person-group><article-title>Molecular characterization of a novel class 1 integron containing bla(GES-1) and a fused product of aac3-Ib/aac6&#x02032;-Ib&#x02019; gene cassettes in Pseudomonas aeruginosa</article-title><source>Antimicrob Agents Chemother</source><year>2002</year><volume>46</volume><fpage>638</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1128/AAC.46.3.638-645.2002</pub-id><pub-id pub-id-type="pmid">11850242</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>RS</given-names></name><etal/></person-group><article-title>Escherichia coli producing CTX-M beta-lactamases in food animals in Hong Kong</article-title><source>Microb Drug Resist</source><year>2006</year><volume>12</volume><fpage>145</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1089/mdr.2006.12.145</pub-id><pub-id pub-id-type="pmid">16922633</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckdahl</surname><given-names>AJ</given-names></name><name><surname>Neal</surname><given-names>R</given-names></name><name><surname>Campbell</surname><given-names>AM</given-names></name><name><surname>Eckdahl</surname><given-names>TT</given-names></name></person-group><article-title>rClone: A synthetic biology tool that enables the research of bacterial translation</article-title><source>J Young Inv</source><year>2017</year><volume>32</volume><fpage>12</fpage><lpage>19</lpage></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Modelling within-host spatiotemporal dynamics of invasive bacterial disease</article-title><source>PLoS Biol</source><year>2008</year><volume>6</volume><fpage>e74</fpage><pub-id pub-id-type="doi">10.1371/journal.pbio.0060074</pub-id><pub-id pub-id-type="pmid">18399718</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname><given-names>L</given-names></name><etal/></person-group><article-title>Granulocytes impose a tight bottleneck upon the gut luminal pathogen population during Salmonella typhimurium colitis</article-title><source>PLoS Pathog</source><year>2014</year><volume>10</volume><fpage>e1004557</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1004557</pub-id><pub-id pub-id-type="pmid">25522364</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>CH</given-names></name><etal/></person-group><article-title>Independent bottlenecks characterize colonization of systemic compartments and gut lymphoid tissue by salmonella</article-title><source>PLoS Pathog</source><year>2014</year><volume>10</volume><fpage>e1004270</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1004270</pub-id><pub-id pub-id-type="pmid">25079958</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muniesa</surname><given-names>M</given-names></name><etal/></person-group><article-title>Bluephage: A rapid method for the detection of somatic coliphages used as indicators of fecal pollution in water</article-title><source>Water Res</source><year>2018</year><volume>128</volume><fpage>10</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.watres.2017.10.030</pub-id><pub-id pub-id-type="pmid">29078067</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinay</surname><given-names>M</given-names></name><etal/></person-group><article-title>Phage-based fluorescent biosensor prototypes to specifically detect enteric bacteria such as E. coli and Salmonella enterica Typhimurium</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><fpage>e0131466</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0131466</pub-id><pub-id pub-id-type="pmid">26186207</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceccaldi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Identification of novel inhibitors of DNA methylation by screening of a chemical library</article-title><source>ACS Chem Biol</source><year>2013</year><volume>8</volume><fpage>543</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1021/cb300565z</pub-id><pub-id pub-id-type="pmid">23294304</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mashhoon</surname><given-names>N</given-names></name><name><surname>Pruss</surname><given-names>C</given-names></name><name><surname>Carroll</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>PH</given-names></name><name><surname>Reich</surname><given-names>NO</given-names></name></person-group><article-title>Selective inhibitors of bacterial DNA adenine methyltransferases</article-title><source>J Biomol Screen</source><year>2006</year><volume>11</volume><fpage>497</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1177/1087057106287933</pub-id><pub-id pub-id-type="pmid">16760373</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>O</given-names></name><name><surname>Lu</surname><given-names>TK</given-names></name></person-group><article-title>Synthetic analog and digital circuits for cellular computation and memory</article-title><source>Curr Opin Biotechnol</source><year>2014</year><volume>29</volume><fpage>146</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1016/j.copbio.2014.04.009</pub-id><pub-id pub-id-type="pmid">24794536</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikel</surname><given-names>PI</given-names></name><name><surname>Silva-Rocha</surname><given-names>R</given-names></name><name><surname>Benedetti</surname><given-names>I</given-names></name><name><surname>de Lorenzo</surname><given-names>V</given-names></name></person-group><article-title>The private life of environmental bacteria: pollutant biodegradation at the single cell level</article-title><source>Environ Microbiol</source><year>2014</year><volume>16</volume><fpage>628</fpage><lpage>642</lpage><pub-id pub-id-type="doi">10.1111/1462-2920.12360</pub-id><pub-id pub-id-type="pmid">24341371</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Datsenko</surname><given-names>KA</given-names></name><name><surname>Wanner</surname><given-names>BL</given-names></name></person-group><article-title>One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2000</year><volume>90</volume><fpage>6640</fpage><lpage>6645</lpage><pub-id pub-id-type="doi">10.1073/pnas.120163297</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellermeier</surname><given-names>CD</given-names></name><name><surname>Janakiram</surname><given-names>A</given-names></name><name><surname>Slauch</surname><given-names>JM</given-names></name></person-group><article-title>Construction of targeted single copy lac fusions using lambda Red and FLP-mediated site-specific recombination in bacteria</article-title><source>Gene</source><year>2002</year><volume>290</volume><fpage>153</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1016/S0378-1119(02)00551-6</pub-id><pub-id pub-id-type="pmid">12062810</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hautefort</surname><given-names>I</given-names></name><name><surname>Proenca</surname><given-names>MJ</given-names></name><name><surname>Hinton</surname><given-names>JC</given-names></name></person-group><article-title>Single-copy green fluorescent protein gene fusions allow accurate measurement of Salmonella gene expression <italic>in vitro</italic> and during infection of mammalian cells</article-title><source>Appl Environ Microbiol</source><year>2003</year><volume>69</volume><fpage>7480</fpage><lpage>7491</lpage><pub-id pub-id-type="doi">10.1128/AEM.69.12.7480-7491.2003</pub-id><pub-id pub-id-type="pmid">14660401</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmieger</surname><given-names>H</given-names></name></person-group><article-title>Phage P22 mutants with increased or decreased transducing abilities</article-title><source>Mol Gen Genet</source><year>1972</year><volume>119</volume><fpage>75</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1007/BF00270447</pub-id><pub-id pub-id-type="pmid">4564719</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garz&#x000f3;n</surname><given-names>A</given-names></name><name><surname>Cano</surname><given-names>DA</given-names></name><name><surname>Casadesus</surname><given-names>J</given-names></name></person-group><article-title>Role of Erf recombinase in P22-mediated plasmid transduction</article-title><source>Genetics</source><year>1995</year><volume>140</volume><fpage>427</fpage><lpage>434</lpage><?supplied-pmid 7498725?><pub-id pub-id-type="pmid">7498725</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>RK</given-names></name><name><surname>Botstein</surname><given-names>D</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Ogata</surname><given-names>Y</given-names></name></person-group><article-title>Specialized transduction of tetracycline by phage P22 in Salmonella typhimurium. II. Properties of a high frequency transducing lysate</article-title><source>Virology</source><year>1972</year><volume>50</volume><fpage>883</fpage><lpage>898</lpage><pub-id pub-id-type="doi">10.1016/0042-6822(72)90442-4</pub-id><pub-id pub-id-type="pmid">4565618</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>RA</given-names></name><name><surname>Keller</surname><given-names>LH</given-names></name><name><surname>Schifferli</surname><given-names>DM</given-names></name></person-group><article-title>Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression</article-title><source>Gene</source><year>1998</year><volume>207</volume><fpage>149</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/S0378-1119(97)00619-7</pub-id><pub-id pub-id-type="pmid">9511756</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertani</surname><given-names>G</given-names></name></person-group><article-title>Studies on lysogenesis. I. The mode of phage liberation by lysogenic</article-title><source>Escherichia coli. J Bacteriol</source><year>1951</year><volume>62</volume><fpage>293</fpage><lpage>300</lpage><?supplied-pmid 14888646?><pub-id pub-id-type="pmid">14888646</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>JH</given-names></name><name><surname>Hinton</surname><given-names>J</given-names></name></person-group><article-title>A protein-free medium for primary isolation of the gonococcus and meningococcus</article-title><source>Exp Biol Med</source><year>1941</year><volume>48</volume><fpage>330</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.3181/00379727-48-13311</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogel</surname><given-names>HJ</given-names></name><name><surname>Bonner</surname><given-names>DM</given-names></name></person-group><article-title>Acetylornithinase of Escherichia coli: partial purification and some properties</article-title><source>J Biol Chem</source><year>1956</year><volume>218</volume><fpage>97</fpage><lpage>106</lpage><?supplied-pmid 13278318?><pub-id pub-id-type="pmid">13278318</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisenstein</surname><given-names>BI</given-names></name></person-group><article-title>Phase variation of type 1 fimbriae in Escherichia coli is under transcriptional control</article-title><source>Science</source><year>1981</year><volume>214</volume><fpage>337</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1126/science.6116279</pub-id><pub-id pub-id-type="pmid">6116279</pub-id></element-citation></ref></ref-list></back></article>